Last reviewed · How we verify
Danshu Capsules
Danshu Capsules is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to improve microcirculation and tissue perfusion.
Danshu Capsules is a traditional Chinese medicine formulation that promotes blood circulation and removes blood stasis to improve microcirculation and tissue perfusion. Used for Diabetic complications (diabetic retinopathy, diabetic nephropathy, diabetic neuropathy), Microcirculation disorders, Cardiovascular disease prevention.
At a glance
| Generic name | Danshu Capsules |
|---|---|
| Also known as | Danshu softgel Capsules |
| Sponsor | Xinhua Hospital, Shanghai Jiao Tong University School of Medicine |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular / Traditional Chinese Medicine |
| Phase | FDA-approved |
Mechanism of action
The capsule contains herbal ingredients traditionally used in Chinese medicine to invigorate blood flow and eliminate stagnant blood. This mechanism is believed to improve oxygen and nutrient delivery to tissues, reduce inflammation, and promote healing. The formulation is typically used to address conditions characterized by poor circulation and microvascular dysfunction.
Approved indications
- Diabetic complications (diabetic retinopathy, diabetic nephropathy, diabetic neuropathy)
- Microcirculation disorders
- Cardiovascular disease prevention
Common side effects
- Gastrointestinal upset
- Allergic reactions
Key clinical trials
- Danshu Capsule and Ursodeoxycholic Acid Capsule in Preventing Recurrence of Choledocholithiasis (PHASE4)
- Effects and Safety of Menthol on Blood Pressure and Metabolic Parameters in Prehypertensive and Mild Hypertensive Patients (PHASE2, PHASE3)
- Pinaverium Bromide in Post-cholecystectomy Sphincter of Oddi Dysfunction (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Danshu Capsules CI brief — competitive landscape report
- Danshu Capsules updates RSS · CI watch RSS
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine portfolio CI